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Background
Recent emergence of artemisinin resistant Plasmodium
falciparum in Southeast Asia has threatened malaria
control efforts across the globe. Clinical resistance is
characterized by reduced rates of parasite clearance fol-
lowing treatment; yet in vitro phenotypes of artemisinin
resistance suitable for elucidating molecular mechanisms
of resistance remain elusive.
Materials and methods
In this study we culture adapted and characterized a series
of P. falciparum clones from Cambodia; these included
parasites from cases with reduced parasite clearance rates
in vivo. In vitro artemisinin resistance phenotypes were
assessed by using T0
3H-hypoxanthine assays, a novel para-
site clearance assay, microscopy and flow cytometry to
characterize intraerythrocytic development, and limiting
dilution to assess parasite viability.
Results
Detailed phenotypic characterization of artemisinin resis-
tant P. falciparum revealed a series of complex phenotypes
that included 4-8 fold resistance to multiple artemisinin
derivatives in vitro that is stable for >1 year. By using a
novel parasite clearance assay we observed reduced parasite
reduction rates (PRRs) for resistant clones in vitro and
these were positively correlated with parasitemia clearance
half-lives in vivo. Most remarkably we discovered an
altered pattern of intraerythrocytic development of the
artemisinin resistant clones of P. falciparum. In the
absence of any drug pressure, resistant clones exhibited a
prolonged phase of ring stage development followed by a
significantly shortened trophozoite stage of development.
Given that ring stages are the most resistant to inhibition
by artemisinin and the trophozoites are the most suscepti-
ble, this novel phenotypic resistance to artemisinin results
in reduced exposure to drug at the most sensitive stage of
development (trophozoite). Additional confirmation of the
selective pressure driving this phenotype is one resistant
clone exhibited a 12 hour shorter erythrocytic life cycle
that also compressed the trophozoite stage of development.
Conclusions
The evolution of artemisinin resistance appears to select
for altered intraerythrocytic development such that the
most susceptible stage of development is significantly
reduced in the cell cycle. Our data demonstrate that
altered intraerythrocytic development is a novel mechan-
ism of phenotypic resistance to artemisinin antimalarial
drugs.
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